Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00430560 · ClinicalTrials.gov registry record · Phase 2
Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia
A Phase 2 study of Schizophrenia and Schizoaffective Disorder, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT00430560 is a Phase 2 study of Schizophrenia and Schizoaffective Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 150 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00430560, a Phase 2 study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This research investigates the benefits of productive activity and cognitive rehabilitation for patients with schizophrenia. Key questions are: 1. does cognitive rehabilitation plus work activity produce better outcomes than work activity alone? 2. Is cognitive rehabilitation more helpful for individuals with moderate or greater cognitive impairment than for individuals without such impairment? 3. Does cognitive rehabilitation reduce the dropout rate and increase participation in work activity for cognitively impaired subjects? 4. What features of cognitive rehabilitation are most important for clinical and rehabilitation outcomes?
Conditions Studied
Interventions
- BEHAVIORAL cognitive rehabilitation
- PROCEDURE work therapy
- BEHAVIORAL work therapy
Study Locations (1)
Connecticut
- VA Connecticut Healthcare System - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2000-10 |
| Est. Completion | 2015-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00430560
The ClinicalTrials.gov registry entry for NCT00430560 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (32% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 3 interventions - of which cognitive rehabilitation is the first listed.
NCT00430560 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00430560 about?
NCT00430560 is a clinical study titled "Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia". This research investigates the benefits of productive activity and cognitive rehabilitation for patients with schizophrenia. Key questions are: 1. does cognitive rehabilitation plus work activity produce better outcomes than work activity alone? 2. Is cognitive rehabilitation more helpful for indiv...
What is the current status of trial NCT00430560?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2000-10. Estimated completion is 2015-10.
What conditions does trial NCT00430560 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.
What interventions are being tested in trial NCT00430560?
The interventions under investigation include: cognitive rehabilitation (BEHAVIORAL), work therapy (PROCEDURE), work therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00430560?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00430560 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia
RECRUITING · Phase 2
-
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
RECRUITING · Phase 2
-
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
RECRUITING · Phase 2
-
Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
RECRUITING · Phase 2
-
Study of ALTO-101 in Patients With Schizophrenia
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.